tiprankstipranks
Trending News
More News >
Plus Therapeutics (PSTV)
NASDAQ:PSTV
US Market

Plus Therapeutics (PSTV) Income Statement

Compare
1,708 Followers

Plus Therapeutics Income Statement

Last quarter (Q4 2025), Plus Therapeutics's total revenue was $1.37M, a decrease of -3.19% from the same quarter last year. In Q4, Plus Therapeutics's net income was $-5.71M. See Plus Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 5.21M$ 5.82M$ 4.91M$ 224.00K$ 0.00
Gross Profit
$ 4.77M$ 4.97M$ -4.78M$ -488.00K$ -66.00K
Operating Expenses
$ 20.07M$ 19.67M$ 8.54M$ 19.22M$ 12.43M
Depreciation and Amortization
$ 445.00K$ 852.00K$ 628.00K$ 712.00K$ 419.00K
EBITDA
$ -14.85M$ -8.40M$ -12.69M$ -18.85M$ -12.05M
Operating Income
$ -15.30M$ -14.70M$ -13.32M$ -19.71M$ -12.49M
Other Income/Expenses
$ -7.09M$ 1.72M$ 5.00K$ -563.00K$ -907.00K
Pretax Income
$ -22.39M$ -12.98M$ -13.32M$ -20.27M$ -13.40M
Net Income
$ -22.39M$ -12.98M$ -13.32M$ -20.27M$ -13.40M
Per Share Metrics
Basic EPS
$ -0.29$ -1.95$ -4.24$ -11.55$ -17.78
Diluted EPS
$ -0.29$ -2.34$ -4.24$ -11.55$ -17.78
Weighted Average Shares Outstanding
778.05M 6.64M 3.14M 1.75M 804.74K
Weighted Average Shares Outstanding (Diluted)
77.80B 7.70M 3.14M 1.75M 805.95K
Currency in USD

Plus Therapeutics Earnings and Revenue History